Wang J Y, Xiong K, Zhao S L, et al. Long-term effects of multi-drug-resistant tuberculosis treatment on gut microbiota and its health consequences[J]. Frontiers in Microbiology, 2020, 11:53
Mulder M, Radjabzadeh D, Kiefte-de Jong J C, et al. Long-term effects of antimicrobial drugs on the composition of the human gut microbiota[J]. Gut Microbes, 2020, 12(1):1795492
Olekhnovich E I, Manolov A I, Samoilov A E, et al. Shifts in the human gut microbiota structure caused by quadruple Helicobacter pylori eradication therapy[J]. Frontiers in Microbiology, 2019, 10:1902
Elvers K T, Wilson V J, Hammond A, et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK:A systematic review[J]. BMJ Open, 2020, 10(9):e035677
McDonnell L, Gilkes A, Ashworth M, et al. Association between antibiotics and gut microbiome dysbiosis in children:Systematic review and meta-analysis[J]. Gut Microbes, 2021, 13(1):1-18
Kobayashi T, Tsuyuguchi K, Yoshida S, et al. Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen[J]. Respiratory Investigation, 2021, 59(2):212-217
Kwon Y S, Han M, Kwon B S, et al. Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease:A propensity score analysis[J]. Journal of Global Antimicrobial Resistance, 2020, 22:106-112
Llorens E, Ginebreda A, la Farré M, et al. Occurrence of regulated pollutants in populated Mediterranean Basins:Ecotoxicological risk and effects on biological quality[J]. The Science of the Total Environment, 2020, 747:141224
Oldenburg C E, Sié A L, Coulibaly B, et al. Effect of commonly used pediatric antibiotics on gut microbial diversity in preschool children in Burkina Faso:A randomized clinical trial[J]. Open Forum Infectious Diseases, 2018, 5(11):ofy289
Vallet N, Le Grand S, Bondeelle L, et al. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation[J]. Blood, 2022, 140(23):2500-2513
Yu J, Chen X, Zhang Y J, et al. Antibiotic Azithromycin inhibits brown/beige fat functionality and promotes obesity in human and rodents[J]. Theranostics, 2022, 12(3):1187-1203
Doan T, Hinterwirth A, Worden L, et al. Gut microbiome alteration in MORDOR I:A community-randomized trial of mass azithromycin distribution[J]. Nature Medicine, 2019, 25(9):1370-1376
Yang X M, Liu X X, Yang C, et al. A conjugative IncI1 plasmid carrying erm(B) and blaCTX-M-104 that mediates resistance to azithromycin and cephalosporins[J]. Microbiology Spectrum, 2021, 9(2):e0028621
Klancic T, Laforest-Lapointe I, Wong J, et al. Concurrent prebiotic intake reverses insulin resistance induced by early-life pulsed antibiotic in rats[J]. Biomedicines, 2021, 9(1):66
Tang Q, Li S Q, Fang C J, et al. Evaluating the reparative effects and the mechanism of action of docosahexaenoic acid on azithromycin-induced lipid metabolism dysfunction[J]. Food and Chemical Toxicology:An International Journal Published for the British Industrial Biological Research Association, 2022, 159:112699
Nikolaou E, Kamilari E, Savkov D, et al. Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose[J]. World Journal of Pediatrics, 2020, 16(2):168-176
Raju S C, Viljakainen H, Figueiredo R A O, et al. Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition[J]. Microbiome, 2020, 8(1):121
Zhao C H, Hu Y F, Chen H H, et al. An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community[J]. PLoS One, 2020, 15(3):e0230200
Guler S A, Clarenbach C, Brutsche M, et al. Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis:A randomized controlled crossover trial[J]. Annals of the American Thoracic Society, 2021, 18(12):2018-2026
Luke D R, Foulds G. Disposition of oral azithromycin in humans[J]. Clinical Pharmacology and Therapeutics, 1997, 61(6):641-648
Maier L S, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria[J]. Nature, 2018, 555(7698):623-628
Rousta E, Oka A, Liu B, et al. The emulsifier carboxymethylcellulose induces more aggressive colitis in humanized mice with inflammatory bowel disease microbiota than polysorbate-80[J]. Nutrients, 2021, 13(10):3565
胡芳, 刘莉, 孟卫. 分光光度法测定阿奇霉素的改进[J]. 光谱实验室, 2011, 28(3):1499-1502 Hu F, Liu L, Meng W. Determination of azithromycin by modified spectrophotometry[J]. Chinese Journal of Spectroscopy Laboratory, 2011, 28(3):1499-1502(in Chinese)
赵昌会, 陈华海, 胡云霏, 等. 氯霉素对体外模拟人体肠道菌群的影响[J]. 应用与环境生物学报, 2023, 29(4):1-10 Zhao C H, Chen H H, Hu Y F, et al. Effect of chloramphenicol on simulated human intestinal microbiota in vitro[J]. Chinese Journal of Applied and Environmental Biology, 2023, 29(4):1-10(in Chinese)
Parker E P K, Praharaj I, John J, et al. Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in South India[J]. Scientific Reports, 2017, 7(1):9168
Li R, Wang H X, Shi Q F, et al. Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice[J]. PLoS One, 2017, 12(7):e0181690
Chaima D, Pickering H, Hart J D, et al. Biannual administrations of azithromycin and the gastrointestinal microbiome of Malawian children:A nested cohort study within a randomized controlled trial[J]. Frontiers in Public Health, 2022, 10:756318
Yin J, Prabhakar M, Wang S, et al. Different dynamic patterns of β-lactams, quinolones, glycopeptides and macrolides on mouse gut microbial diversity[J]. PLoS One, 2015, 10(5):e0126712
Ren X H, Xu J, Zhang Y Y, et al. Bacterial alterations in post-cholecystectomy patients are associated with colorectal cancer[J]. Frontiers in Oncology, 2020, 10:1418
Chung The H, Nguyen Ngoc Minh C, Tran Thi Hong C, et al. Exploring the genomic diversity and antimicrobial susceptibility of Bifidobacterium pseudocatenulatum in a Vietnamese population[J]. Microbiology Spectrum, 2021, 9(2):e0052621
Ayerbe L, Risco-Risco C, Forgnone I, et al. Azithromycin in patients with COVID-19:A systematic review and meta-analysis[J]. The Journal of Antimicrobial Chemotherapy, 2022, 77(2):303-309
Hazan S. Microbiome-based hypothesis on ivermectin's mechanism in COVID-19:Ivermectin feeds bifidobacteria to boost immunity[J]. Frontiers in Microbiology, 2022, 13:952321
Fan S N, Zhang K, Zhang J H, et al. Analysis of the effect of phototherapy on intestinal probiotics and metabolism in newborns with jaundice[J]. Frontiers in Pediatrics, 2022, 10:878473
Li X Y, Feng R, Zhou P, et al. Construction and characterization of Juglans regia L. polyphenols nanoparticles based on bovine serum albumin and Hohenbuehelia serotina polysaccharides, and their gastrointestinal digestion and colonic fermentation in vitro[J]. Food & Function, 2021, 12(21):10397-10410
Wang H H, Zhang K B, Wu L, et al. Prediction of pathogenic factors in dysbiotic gut microbiomes of colorectal cancer patients using reverse microbiomics[J]. Frontiers in Oncology, 2022, 12:882874
Xi Y, Liu F, Qiu B, et al. Analysis of gut microbiota signature and microbe-disease progression associations in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy[J]. Frontiers in Cellular and Infection Microbiology, 2022, 12:892401
Huang R, He K, Duan X P, et al. Changes of intestinal microflora in colorectal cancer patients after surgical resection and chemotherapy[J]. Computational and Mathematical Methods in Medicine, 2022, 2022:1940846
Yang X, Tang T, Wen J, et al. Effects of S24-7 on the weight of progeny rats after exposure to ceftriaxone sodium during pregnancy[J]. BMC Microbiology, 2021, 21(1):166
Wen M, Liu T H, Zhao M Y, et al. Correlation analysis between gut microbiota and metabolites in children with systemic lupus erythematosus[J]. Journal of Immunology Research, 2021, 2021:5579608
Chen G L, Zhang Y, Wang W Y, et al. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities[J]. World Journal of Gastroenterology, 2017, 23(25):4624-4631
Kim S W, Van Kessel J A S, Haley B J. Genome sequences of antibiotic-resistant Escherichia coli isolated from veal calves in the USA[J]. Journal of Global Antimicrobial Resistance, 2021, 26:69-73
Serafini F, Bottacini F, Viappiani A, et al. Insights into physiological and genetic mupirocin susceptibility in bifidobacteria[J]. Applied and Environmental Microbiology, 2011, 77(9):3141-3146
Tóth A G, Csabai I, Maróti G, et al. A glimpse of antimicrobial resistance gene diversity in kefir and yoghurt[J]. Scientific Reports, 2020, 10:22458
Zhang X, Zhao H X, Du J, et al. Occurrence, removal, and risk assessment of antibiotics in 12 wastewater treatment plants from Dalian, China[J]. Environmental Science and Pollution Research International, 2017, 24(19):16478-16487